Related Experiment Video
Updated: Jan 29, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Combined Heart and Kidney Transplantation: Clinical Experience in 100 Consecutive Patients
Morcos Atef Awad1, Lawrence S C Czer1, Dominic Emerson2
11 Division of Cardiology Cedars-Sinai Smidt Heart Institute the Multiorgan Transplant Program Cedars-Sinai Medical Center Los Angeles CA.
Insights
Combined heart and kidney transplantation (HKT x) is safe for patients aged 60 and older, or younger, and for those on or off dialysis. Sensitization levels did not impact survival rates in this study.
Area of Science:
- Cardiology
- Nephrology
- Transplantation Immunology
Background:
- Combined heart and kidney transplantation (HKT x) addresses severe heart failure and advanced renal insufficiency.
- Patient selection criteria and outcomes for HKT x require ongoing evaluation.
Purpose of the Study:
- To analyze long-term survival after HKT x.
- To assess the influence of recipient age and dialysis status on HKT x outcomes.
- To evaluate cardiac rejection rates and the impact of sensitization on survival.
Main Methods:
- A retrospective analysis of 100 HKT x procedures performed between June 1992 and December 2016.
- Comparison of outcomes between older (≥60 years) and younger (<60 years) recipients.
- Comparison of outcomes between recipients on preoperative dialysis and those not on dialysis.
- Analysis of cardiac rejection (any, acute cellular, antibody-mediated) and survival rates stratified by panel-reactive antibody (PRA) levels.
Main Results:
- No significant difference in 15-year survival was observed between age groups (≥60 vs. <60 years) or between dialysis and non-dialysis groups.
- High rates of freedom from rejection were noted at 30 days and 1 year post-transplant.
- No significant difference in 5-year survival was found across different PRA sensitization levels (<10%, 10%-50%, >50%).
- Long-term survival at our center was comparable to the United Network for Organ Sharing database.
Conclusions:
- Combined heart and kidney transplantation is a safe and effective procedure for a wide range of patients, including older individuals and those with varying dialysis dependence.
- Pre-transplant sensitization, as indicated by PRA levels, does not appear to adversely affect long-term survival after HKT x.
Abstract:
Background Combined heart and kidney transplantation ( HKT x) is performed in patients with severe heart failure and advanced renal insufficiency. We analyzed the long-term survival after HKT x, the influence of age and dialysis status, the rates of cardiac rejection, and the influence of sensitization. Methods and Results From June 1992 to December 2016, we performed 100 HKT x procedures. We compared older (≥60 years, n=53) with younger (<60 years, n=47) recipients, and recipients on preoperative dialysis (n=49) and not on dialysis (n=51). We analyzed actuarial freedom from any cardiac rejection, acute cellular rejection, and antibody-mediated rejection, and survival rates by sensitized status with panel-reactive antibody levels <10%, 10% to 50%, and >50%, and compared these survival rates with those from the United Network for Organ Sharing database. There was no difference in 15-year survival between the 2 age groups (35±12.4% and 49±17.3%, ≥60 versus <60 years; P=0.45). There was no difference in 15-year survival between the dialysis and nondialysis groups (44±13.4% and 37±15.2%, P=0.95). Actuarial freedom from any cardiac rejection ( acute cellular rejection >0 or antibody-mediated rejection >0) was 92±2.8% and 84±3.8%, acute cellular rejection (≥2R/3A) 98±1.5% and 94±2.5%, and antibody-mediated rejection (≥1) 96±2.1% and 93±2.6% at 30 days and 1 year after HKT x. There was no difference in the 5-year survival among recipients by sensitization status with panel-reactive antibody levels <10%, 10% to 50%, and >50% (82±5.9%, 83±10.8%, and 92±8.0%; P=0.55). There was no difference in 15-year survival after HKT x between the United Network for Organ Sharing database and our center (38±3.2% and 40±10.1%, respectively; P=0.45). Conclusions HKT x is safe to perform in patients 60 years and older or younger than 60 years and with or without dialysis dependence, with excellent outcomes. The degree of panel-reactive antibody sensitization did not appear to affect survival after HKT x.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease II: Clinical Manifestations
Kidney Transplant III: Nursing Management
Heart Failure III: Clinical Manifestations
Acute Kidney Injury III: Clinical Manifestations

